Suchergebnisse - "Dixon, Kate J"

PubPharm (5)

1

iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting

enthalten in: Journal for immunotherapy of cancer | 2023

von Snyder, K. | Dixon, K. | Davis, Z. | +11

ErratumIn: J Immunother Cancer. 2023 Dec 28;11(12):. - PMID 38154859

2

MyD88 is an essential regulator of NK cell-mediated clearance of MCMV infection

enthalten in: Molecular immunology | 2021

von Dixon, K. | Siebert, J. | Wang, D. | +7

3

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells

enthalten in: Cancers | 2021

von Dixon, K. | Wu, J. | Walcheck, B.

4

Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation

enthalten in: Frontiers in immunology | 2021

von Mishra, H. | Dixon, K. | Pore, N. | +3

5

IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells

enthalten in: Frontiers in immunology | 2018

von Abel, A. | Tiwari, A. | Gerbec, Z. | +6

1
[1]